Antonelli Financial Advisors LLC Acquires Shares of 1,491 UnitedHealth Group Incorporated (NYSE:UNH)

Antonelli Financial Advisors LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, HoldingsChannel reports. The firm purchased 1,491 shares of the healthcare conglomerate’s stock, valued at approximately $754,000. UnitedHealth Group comprises 0.6% of Antonelli Financial Advisors LLC’s portfolio, making the stock its 26th biggest position.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $512.30 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $468.61 billion, a PE ratio of 33.05, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s fifty day simple moving average is $510.24 and its 200-day simple moving average is $547.97.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm earned $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.